APA (7th ed.) Citation

Ahmadvand, M., Barough, M. S., Hashemi, Z. S., Sanati, H., Abbasvandi, F., Yunesian, M., . . . Forooshani, R. S. (2023). Safety and feasibility study of ex vivo expanded allogeneic-NK cells infusion in patients with acute pneumonia caused by COVID-19. Pilot & Feasibility Studies, 9(1), 1. https://doi.org/10.1186/s40814-023-01355-6

Chicago Style (17th ed.) Citation

Ahmadvand, Mohammad, et al. "Safety and Feasibility Study of Ex Vivo Expanded Allogeneic-NK Cells Infusion in Patients with Acute Pneumonia Caused by COVID-19." Pilot & Feasibility Studies 9, no. 1 (2023): 1. https://doi.org/10.1186/s40814-023-01355-6.

MLA (9th ed.) Citation

Ahmadvand, Mohammad, et al. "Safety and Feasibility Study of Ex Vivo Expanded Allogeneic-NK Cells Infusion in Patients with Acute Pneumonia Caused by COVID-19." Pilot & Feasibility Studies, vol. 9, no. 1, 2023, p. 1, https://doi.org/10.1186/s40814-023-01355-6.